Triple Trouble: A Case of Multiple Resistance Mechanisms after First Generation EGFR-TKI in NSCLC
Epidermal growth factor receptor (EGFR)-targeted therapy has become standard of care in advanced stages EGFR-mutant non-small cell lung cancer. Acquired resistance to first-line EGFR-tyrosine kinase inhibitor (TKI) and subsequent disease progression is a common problem and mostly due to a secondary...
| Автори: | , , , , |
|---|---|
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
Karger Publishers
2019-08-01
|
| Серія: | Case Reports in Oncology |
| Предмети: | |
| Онлайн доступ: | https://www.karger.com/Article/FullText/502214 |